| APIsky Chemical Co.,Ltd. |
 |
 |
제조+판매 |
 |
|
 |
The South of KaiTuoLu Road
GaoXinQu District |
 |
+86-531-82312560 |
 |
+86-531-82312563 |
 |
CHINA |
 |
Jason Fan |
 |
sales@apisky.com |
 |
www.apisky.com
|
|
|
|
 |
회사소개
Jinan Chenghui-Shuangda Chemical Co., Ltd.(CHSD)is a professional company, mainly focusing on the producing and marketing of active pharmaceutical ingredients(APIs) and their intermediates.
If you're looking for a supplier of worldwide APIs for your most powerful business, you've come to the exact site. Here, at CHSD , best pricing, high quality products and secure delivery are just the beginning. Customizing our services to meet your all requirements is our final goal. While CHSD wants to be the strongest APIs and intermediates supplier, we desire to be your first choice when you think about service. We are sure our powerful supplying solutions and service will be your first choice in the APIs and intermediates industry.
The headquarters of the company was established in Jinan, China with a R&D Center for new products. There are many new special and competitive varieties developed by our company according to its advanced technology and flexible operating method. Cooperating with many famous national pharmaceutical enterprises, in recently years, the R& D Center of our company has developed many new products. Three chemical production factories and two GMP workshop were established to meet the market’s requirements, which are the combination of science, technique and trade.
Since its beginning in 1994, CHSD is based on the production of unique and competitive varieties under the support of its advanced technology. At present, our company has made notable advancements in internationalizing its business & implementing global policies & strategies. It now proudly caters to meet the APIs requirements from reputed customers located in the US, UK, Canada, Japan, Australia, South Americas, Singapore, Taiwan, Thailand and various other countries.
For you, we can supply the most competitive pharmaceutical products, with excellent quality and fair price as follows:
1.Cyclopentato pyridine(CPP): The product is an important intermediate of Cefpirome sulfate. Our company has established a production device of 5000 kg/month, we are the first one in China to produce this product in large scales. Domestic and overseas markets are both supplied.
2.The Caine series of Prilocaine Hydrochloride,Pramoxine Hydrochloride, Cinchocaine Hydrochloride, Ropivacaine Hydrochloride(Mesylate), Bupivacaine Hydrochloride and Mepivacaine Hydrochloride is one of the main product series developed by our company. Prilocaine Hydrochloride,Cinchocaine Hydrochloride and Mepivocaine Hydrochloride are unique in china, which meets the quality requirements of USP29.
3. Levodropropizine: Our factory's production facility for this variety is the largest scale within china, with a production capability of more than 1000kg per month. The product quality meets the European Pharmacopoeia Standards. Moreover the dextrodropropizine content is no more than 0.5%，which is much lower than the standard of NMT2.0% in European pharmacopoeia. All the product is sold abroad.
4. Ozagrel: The production capability is 200kg per month and the product quality reaches the China National Standards as well as the analysis for the related substance are less than 0.5%(HPLC method)to meet the need of injection form.
5. Tiopronin: The company has established a production device of 1000kg/month for this variety, producing products of various specifications including 98.0%, 98.5%, 99.0% and 99.5% to meet market requirements of different clients. In order to meet the strict requirements of the product quality for domestic injection manufacturers, HPLC related substance testing method is added to the standard of these products.
6. Donepezil Hydrochloride: We own the largest scale production facility within China for this variety with a production capability of more than 200kg per month. Additionally, we can supply four quality standards: 99.0%, 99.5%, 99.8%, 99.9% respectively.
|
 |
|
|
